Inventor · disambiguated record
Michael E. Garst
Also filed as: GARST MICHAEL · GARST MICHAEL E · GARST MICHAEL ELWOOD
212 granted patents·46 pending applications·3,436 citations·filing 1986–2023
99Inventor score
Top patents by PatentIndex Score
258 records- 0199US6403649B1Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agentsALLERGAN SALES INC·Filed 2000·Granted Jun 11, 2002·272 cites·3 claims
- 0298US8017655B2Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agentsALLERGAN INC·Filed 2008·Granted Sep 13, 2011·24 cites·6 claims
- 0398US6350442B2Ocular treatment using cyclosporin-A derivativesALLERGAN SALES INC·Filed 2001·Granted Feb 26, 2002·151 cites·7 claims
- 0498US5688819ACyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agentsALLERGAN INC·Filed 1996·Granted Nov 18, 1997·309 cites·20 claims
- 0597US7091232B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·112 cites·3 claims
- 0697US6534542B2(2-hydroxy)ethyl-thioureas useful as modulators of α2B adrenergic receptorsALLERGAN INC·Filed 2001·Granted Mar 18, 2003·82 cites·54 claims
- 0797US6329369B1Methods of treating pain and other conditionsALLERGAN SALES INC·Filed 2000·Granted Dec 11, 2001·83 cites·17 claims
- 0897US5352708ANon-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agentsALLERGAN INC·Filed 1992·Granted Oct 4, 1994·195 cites·8 claims
- 0996US6747025B1Kinase inhibitors for the treatment of diseaseALLERGAN INC·Filed 2003·Granted Jun 8, 2004·57 cites·9 claims
- 1096US6254860B1Ocular treatment using cyclosporin-A derivativesALLERGAN SALES INC·Filed 1999·Granted Jul 3, 2001·146 cites·10 claims
- 1194US9579307B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2016·Granted Feb 28, 2017·9 cites·7 claims
- 1294US8658803B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Feb 25, 2014·16 cites·6 claims
- 1394US6841684B2Imidiazoles having reduced side effectsALLERGAN INC·Filed 2001·Granted Jan 11, 2005·72 cites·18 claims
- 1494US5607978ANon-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agentsALLERGAN INC·Filed 1995·Granted Mar 4, 1997·117 cites·8 claims
- 1593US10172832B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2018·Granted Jan 8, 2019·6 cites·1 claims
- 1693US9351948B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2015·Granted May 31, 2016·9 cites·7 claims
- 1793US8993780B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2013·Granted Mar 31, 2015·13 cites·4 claims
- 1893US8618163B2Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activityBEARD RICHARD L·Filed 2011·Granted Dec 31, 2013·7 cites·8 claims
- 1993US6559167B1Prodrugs of proton pump inhibitorsUNIV CALIFORNIA·Filed 2001·Granted May 6, 2003·65 cites·20 claims
- 2093US5721215AInjectable therapy for control of muscle spasms and pain related to muscle spasmsALLERGAN INC·Filed 1996·Granted Feb 24, 1998·112 cites·18 claims
- 2192US9974772B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2017·Granted May 22, 2018·6 cites·6 claims
- 2292US8580817B21-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsBEARD RICHARD L·Filed 2012·Granted Nov 12, 2013·8 cites·13 claims
- 2392US7323485B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Jan 29, 2008·7 cites·5 claims
- 2492US6545182B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2001·Granted Apr 8, 2003·79 cites·15 claims
- 2591US8541577B2Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Sep 24, 2013·13 cites·3 claims
- 2691US7335803B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN INC·Filed 2001·Granted Feb 26, 2008·40 cites·3 claims
- 2791US5453434AN-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidoneALLERGAN INC·Filed 1994·Granted Sep 26, 1995·63 cites·5 claims
- 2890US8791161B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jul 29, 2014·7 cites·14 claims
- 2990US7902247B2Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsALLERGAN INC·Filed 2008·Granted Mar 8, 2011·12 cites·15 claims
- 3090US7345077B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2005·Granted Mar 18, 2008·12 cites·20 claims
- 3190US6313172B1Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·42 cites·10 claims
- 3290US6294563B1Combinations of prostaglandins and brimonidine or derivatives thereofALLERGAN SALES INC·Filed 1999·Granted Sep 25, 2001·87 cites·7 claims
- 3390US6271220B1Anti-angiogenic agentsALLERGAN SALES INC·Filed 1998·Granted Aug 7, 2001·95 cites·6 claims
- 3489US8927544B2Benzofuran-2-sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jan 6, 2015·4 cites·6 claims
- 3589US8809367B21-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 19, 2014·5 cites·13 claims
- 3689US7399868B24-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 15, 2008·11 cites·7 claims
- 3789US5756503AMethods for using (2-imidazolin-2-ylamino) Quinoxaline derivativesALLERGAN INC·Filed 1996·Granted May 26, 1998·55 cites·17 claims
- 3889US2024285584A1Amide derivatives of n-urea substituted amino acids as formyl peptidereceptor like-1 (fprl-1) receptor modulatorsALLERGAN INC·Filed 2023·Application pending·0 cites
- 3988US10993931B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2018·Granted May 4, 2021·1 cites·5 claims
- 4088US10301269B2Imidazole derivatives as formyl peptide receptor modulatorsALLERGAN INC·Filed 2015·Granted May 28, 2019·3 cites·10 claims
- 4188US8816076B2Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 26, 2014·9 cites·8 claims
- 4288US8492556B22,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Jul 23, 2013·11 cites·15 claims
- 4388US7419994B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·8 cites·16 claims
- 4488US6093734AProdrugs of proton pump inhibitorsPARTNERSHIP OF MICHAEL E GARST·Filed 1998·Granted Jul 25, 2000·61 cites·10 claims
- 4588US5703077AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1996·Granted Dec 30, 1997·49 cites·19 claims
- 4687US8450367B2Sulfur derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted May 28, 2013·7 cites·16 claims
- 4787US8063231B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Nov 22, 2011·4 cites·1 claims
- 4887US6452032B1Organosilyl compounds having nuclear hormone receptor modulating activityALLERGAN SALES LLC·Filed 2000·Granted Sep 17, 2002·27 cites·34 claims
- 4987US6203794B1Modification of clostridial toxins for use as transport proteinsALLERGAN SALES INC·Filed 1995·Granted Mar 20, 2001·74 cites·14 claims
- 5087US5561132AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1995·Granted Oct 1, 1996·47 cites·17 claims
Showing the top 50 of 258 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael E. Garst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →